4 results match your criteria: "Birla Institute of Technology and Science (BITS) Pilani-Dubai Campus[Affiliation]"

Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet.

Biochim Biophys Acta Mol Cell Biol Lipids

October 2024

Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA; Department of Nutritional Sciences, University of Wisconsin-Madison, 1415 Linden Drive, Madison, WI 53706, USA. Electronic address:

Stearoyl-CoA desaturase-1 (SCD1) is a pivotal enzyme in lipogenesis, which catalyzes the synthesis of monounsaturated fatty acids (MUFA) from saturated fatty acids, whose ablation downregulates lipid synthesis, preventing steatosis and obesity. Yet deletion of SCD1 promotes hepatic inflammation and endoplasmic reticulum stress, raising the question of whether hepatic SCD1 deficiency promotes further liver damage, including fibrosis. To delineate whether SCD1 deficiency predisposes the liver to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC), we employed in vivo SCD1 deficient global and liver-specific mouse models fed a high carbohydrate low-fat diet and in vitro established AML12 mouse cells.

View Article and Find Full Text PDF

Cranberry phytochemicals are known to possess antiviral activities. In the current study, we explored the therapeutic potential of cranberry against SARS-CoV-2 by targeting its main protease (M) enzyme. Firstly, phytochemicals of cranberry origin were identified from three independent databases.

View Article and Find Full Text PDF
Article Synopsis
  • - Cholangiocarcinoma (CCA) is a type of liver cancer with rising cases and poor treatment options, making it crucial to find new therapeutic targets for better disease management.
  • - This study investigates the role of chaperones in CCA by mapping their expression in cancer samples and analyzing their involvement in important cancer pathways, identifying two promising targets: CRYAB and P4HA2.
  • - Utilizing drug repurposing, the research found that the existing cancer drugs tucatinib and regorafenib could inhibit these chaperones, potentially leading to new treatment strategies for CCA.
View Article and Find Full Text PDF